Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123857263 | 12385726 | 3 | F | 20160429 | 20160628 | 20160519 | 20160706 | EXP | US-AMGEN-USACT2016061750 | AMGEN | 65.00 | YR | E | F | Y | 0.00000 | 20160706 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123857263 | 12385726 | 1 | PS | carfilzomib | CARFILZOMIB | 1 | Intravenous (not otherwise specified) | 36 MG/M2, PER CHEMO REGIM | 202714 | 36 | MG/M**2 | INTRAVENOUS INFUSION | |||||||
| 123857263 | 12385726 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 10 MG, PER CHEMO REGIM | 0 | 10 | MG | TABLET | |||||||
| 123857263 | 12385726 | 3 | SS | IBRUTINIB | IBRUTINIB | 1 | Oral | 280 MG, QD | 4760 | MG | L0500397A7 | 0 | 280 | MG | CAPSULE | QD | |||
| 123857263 | 12385726 | 4 | C | ZOVIRAX | ACYCLOVIR | 1 | UNK | 0 | |||||||||||
| 123857263 | 12385726 | 5 | C | NEURONTIN | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 123857263 | 12385726 | 6 | C | EMLA | LIDOCAINEPRILOCAINE | 1 | UNK | 0 | |||||||||||
| 123857263 | 12385726 | 7 | C | ATIVAN | LORAZEPAM | 1 | UNK | 0 | |||||||||||
| 123857263 | 12385726 | 8 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 123857263 | 12385726 | 9 | C | POTASSIUM | POTASSIUM | 1 | UNK | 0 | |||||||||||
| 123857263 | 12385726 | 10 | C | PEPTO-BISMOL | BISMUTH SUBSALICYLATE | 1 | UNK | 0 | |||||||||||
| 123857263 | 12385726 | 11 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 123857263 | 12385726 | 12 | C | ONDANSETRON | ONDANSETRON | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123857263 | 12385726 | 1 | Plasma cell myeloma |
| 123857263 | 12385726 | 2 | Plasma cell myeloma |
| 123857263 | 12385726 | 3 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123857263 | 12385726 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123857263 | 12385726 | Cardiac failure congestive | |
| 123857263 | 12385726 | Pneumonia | |
| 123857263 | 12385726 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123857263 | 12385726 | 1 | 20160413 | 20160426 | 0 | |
| 123857263 | 12385726 | 2 | 20160413 | 20160426 | 0 | |
| 123857263 | 12385726 | 3 | 20160413 | 20160429 | 0 | |
| 123857263 | 12385726 | 4 | 20151130 | 0 | ||
| 123857263 | 12385726 | 6 | 20150518 | 0 | ||
| 123857263 | 12385726 | 7 | 20160328 | 0 | ||
| 123857263 | 12385726 | 11 | 20160505 | 0 |